Integrated Behavioral Health Innovations in Childhood Chronic Illness Care Delivery Systems

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2018-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study design: At baseline, all adolescents and young adults with IBD ages 12-21 years will be screened for anxiety and depression symptoms using the PHQ-9 and the Screen for Child Anxiety Related Disorders (SCARED) during a routine medical visit in the pediatric gastroenterology clinic. Individuals who screen positive for depression or anxiety will be assessed to confirm diagnoses using the anxiety and M.I.N.I. 6.0. Participants will also complete a psychosocial risk assessment as well as medical and socio-demographic inventories. The investigators will include youth that meet full criteria for major depressive disorder and any anxiety disorder, dysthymic disorder, and any adjustment disorder. The investigators will also include patients with subclinical symptoms that have significant psychosocial stressors in addition to their medical illness. Patients will be excluded if they have active suicidal ideation with plan requiring ER referral, bipolar disorder, psychosis, substance dependence, eating disorders, or significant intellectual disability/developmental delay. Participants meeting inclusion criteria will be randomly assigned to four sessions of IBBT administered on-site by a Fink social worker or treatment as usual (TAU), which is a facilitated community referral for mental health treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Reducing Depressive Symptoms in Physically Ill Youth

NCT00534911

Inflammatory Bowel Disease Depression

COMPLETED NA

Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness

NCT00769353

Inflammatory Bowel Disease Ulcerative Colitis Crohn's Disease +1 more

COMPLETED NA

Treatment of Depressed Adolescents With Physical Illness

NCT00446238

Inflammatory Bowel Disease Depression

COMPLETED NA

Brief CBT for the Treatment of Depression During Inpatient Hospitalization

NCT03011619

Depression

WITHDRAWN NA

Between the Belly and the Brain: Distorted Gut-brain Crosstalk in Early-life Adversity

NCT06922773

Early Life Adversity Microbiome, Human Anxiety Symptoms +2 more

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Integrated Brief Behavior Therapy (IBBT) Intervention

4-sessions of IBBT for youth anxiety and depression.

Group Type EXPERIMENTAL

Integrated Brief Behavior Therapy (IBBT) Intervention

Intervention Type BEHAVIORAL

The 4 sessions will empower and support families and youth to continue treatment autonomously with home practice

Treatment as usual

Group Type ACTIVE_COMPARATOR

Treatment as usual

Intervention Type BEHAVIORAL

Facilitated community referral for mental health treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Integrated Brief Behavior Therapy (IBBT) Intervention

The 4 sessions will empower and support families and youth to continue treatment autonomously with home practice

Intervention Type BEHAVIORAL

Treatment as usual

Facilitated community referral for mental health treatment

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adolescents and young adults with IBD ages 12-21 years will be screened for anxiety and depression symptoms and includes youth that meet full criteria for major depressive disorder and any anxiety disorder, dysthymic disorder, and any adjustment disorder. The investigators will also include patients with subclinical symptoms that have significant psychosocial stressors in addition to their medical illness.

Exclusion Criteria

* Patients will be excluded if they have active suicidal ideation with plan requiring ER referral, bipolar disorder, psychosis, substance dependence, eating disorders, or significant intellectual disability/developmental delay.

Minimum Eligible Age

12 Years

Maximum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No